{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Newbury Park",
      "address_1": "914 Tourmaline Drive",
      "reason_for_recall": "Marketed without an approved NDA/ANDA: INK-EEZE Tattoo Numbing Spray contains 5% Lidocaine and is being marketed without an approved NDA/ANDA. Lidocaine 5% is an ingredient in many FDA approved products, making Ink-Eeze an unapproved new drug.",
      "address_2": "",
      "product_quantity": "683 Bottles",
      "code_info": "Lot L0207",
      "center_classification_date": "20130627",
      "distribution_pattern": "California and Colorado.",
      "state": "CA",
      "product_description": "INK-EEZE Tattoo Numbing Spray, 2 oz. (59 mL),   Active Ingredients: Lidocaine HCl 5% Topical Anesthetic, Distributed by: Indelicare, LLC 914 Tourmaline Drive, Newbury Park, CA 91320, (800) 611-7720, www.inkeeze.com",
      "report_date": "20130703",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Indelicare LLC",
      "recall_number": "D-621-2013",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "65284",
      "termination_date": "20140630",
      "more_code_info": "",
      "recall_initiation_date": "20130523",
      "postal_code": "91320",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}